Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich: Feb 8, 2007

Premium
Sigma-Aldrich is offering two RNAi workshops covering the gene-silencing technology and its research applications.
The workshops are being held March 20-22 at the Sigma Life Science and High Technology Center in St. Louis. The first will cover synthetic and viral-based systems for gene silencing, and will include topics such as siRNA and shRNA methodologies, vector-based shRNA, titer methods, and high-throughput screening.
 
The second workshop will cover knockdown quantitation technologies and will include such topics as qRT-PCR.
 
Registration for the workshops ends Feb. 28.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.